Microbial enzyme helps to churn out scarce COVID drug at full tilt
Abstract
Synthesis of the COVID-19 antiviral molnupiravir is easier and more efficient when a bacterial enzyme is on the job.
- Publication:
-
Nature
- Pub Date:
- March 2022
- DOI:
- 10.1038/d41586-022-00675-6
- Bibcode:
- 2022Natur.603..366.